Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. 8-K Event Acquisition or sale completed
  2. DEFA14A Proxy Proxy Materials
  3. DEF 14A Proxy Proxy Statement
  4. 424B5 Offering Prospectus
  5. 8-K Event Material agreement
  6. PRE 14A Proxy Proxy Statement (Preliminary)
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Material agreement · Other events
  9. S-3 Offering Registration Statement
  10. 8-K Event Other events
  11. CT ORDER Other Confidential Order
  12. 424B5 Offering Prospectus
  13. 8-K Event Material agreement · Other events
  14. 424B5 Offering Prospectus
  15. 8-K Event Material agreement · Other events
  16. 8-K/A Event Exhibits
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 8-K Event Other events
  20. 8-K Event Material agreement · Other events

Page 47 of 64 · 1,276 filings